Welcome to LookChem.com Sign In|Join Free
  • or
Salicylaldehyde semicarbazone, a compound formed by the reaction of salicylaldehyde and semicarbazide, is a yellow crystalline solid with a molecular formula of C14H14N4O2 and a molar mass of 270.29 g/mol. It has a melting point of 188-190°C and is sparingly soluble in water. Salicylaldehyde semicarbazone is known for its potential biological activities, including antimicrobial and antitumor properties, and is commonly used as a reagent in organic synthesis, particularly in the preparation of heterocyclic compounds.

3030-97-5

Post Buying Request

3030-97-5 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

3030-97-5 Usage

Uses

Used in Organic Synthesis:
Salicylaldehyde semicarbazone is used as a reagent in organic synthesis for the preparation of heterocyclic compounds due to its unique chemical structure and properties.
Used in Environmental Analysis:
Salicylaldehyde semicarbazone is used as a reagent in the determination of copper and zinc in industrial wastewater, helping to monitor and control the levels of these heavy metals in the environment.
Used in Pharmaceutical Research:
Salicylaldehyde semicarbazone is studied for its potential biological activities, such as antimicrobial and antitumor properties, making it a promising candidate for the development of new drugs and therapies in the pharmaceutical industry.

Check Digit Verification of cas no

The CAS Registry Mumber 3030-97-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 3,0,3 and 0 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 3030-97:
(6*3)+(5*0)+(4*3)+(3*0)+(2*9)+(1*7)=55
55 % 10 = 5
So 3030-97-5 is a valid CAS Registry Number.
InChI:InChI=1/C8H9N3O2/c9-8(13)11-10-5-6-3-1-2-4-7(6)12/h1-5,12H,(H3,9,11,13)/b10-5+

3030-97-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Hydrazinecarboxamide,2-[(2-hydroxyphenyl)methylene]-

1.2 Other means of identification

Product number -
Other names o-hydroxybenzaldehyde semicarbazone

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:3030-97-5 SDS

3030-97-5Relevant academic research and scientific papers

Synthesis and structural studies of mono- and dinuclear Cu(II) complexes with an ONO donor Schiff base ligand: Self-assembly and sulfato-bridged

Vafazadeh, Rasoul,Esteghamat-Panah, Roya,Willis, Anthony C.,Hill, Anthony F.

, p. 51 - 57 (2012)

Five Cu(II) complexes, [CuL(NO3)] (1), [CuLBr][CuLCH 3OH]2Br2 (2), [CuLN3] (3), [CuL(ClO4)]2 (4) and [H2OLCu(μ-SO 4)CuLH2O] (5), where L is the s

In-house chemical library repurposing: A case example for Pseudomonas aeruginosa antibiofilm activity and quorum sensing inhibition

Ravithej Singh,Tripathi, Vikash C.,Raj, Sneha,Kumar, Anoop,Gupta, Sampa,Horam, Soyar,Upadhyay, Akanksha,Kushwaha, Pragati,Arockiaraj, Jesu,Sashidhara, Koneni V.,Pasupuleti, Mukesh

, p. 383 - 390 (2018)

(Table presented.). Drug repurposing has become a recent trend in drug development programs, where previously developed drugs are explored for hit and redeveloped into potential therapeutic agents for new diseases. Globally, in any drug development progra

Synthesis of O-Sulfated Human Syndecan-1-like Glyco-polypeptides by Incorporating Peptide Ligation and O-Sulfated Glycopeptide Cassette Strategies

Huang, Xuefei,Li, Tianlu,Ramadan, Sherif,Yang, Weizhun

, p. 6429 - 6433 (2020)

A successful synthesis of O-sulfated syndecan-1-like (Q23-E120) glyco-polypeptide was accomplished. The synthesis features the integration of an O-sulfated carbohydrate-bearing glycopeptide cassette with efficient protein ligation strategies, overcoming the acid lability of carbohydrate sulfates as a major hurdle in solid-phase peptide synthesis. Crucial to the synthesis is the microwave-assisted Ag(I) ligation, which afforded the ligation product in improved overall yield. This O-sulfated syndecan-1 (Q23-E120) is the longest O-sulfated glyco-polypeptide prepared to date.

New Vanadium(v) Complexes with Salicylaldehyde Semicarbazone Derivatives: Synthesis, Characterization, and in vitro Insulin-Mimetic Activity - Crystal Structure of [VVO2(salicylaldehyde semicarbazone)]

Noblia, Pabla,Baran, Enrique J.,Otero, Lucia,Draper, Patricia,Cerecetto, Hugo,Gonzalez, Mercedes,Piro, Oscar E.,Castellano, Eduardo E.,Inohara, Toshifumi,Adachi, Yusuke,Sakurai, Hiromu,Gambino, Dinorah

, p. 322 - 328 (2004)

The new dioxo(semicarbazone)vanadium(v) complexes cis-VO2L, where L = salicylaldehyde semicarbazone (L1), salicylaldehyde 4-n-butylsemicarbazone (L2), or salicylaldehyde 4-(2-naphthyl)semicarbazone (L3), have been synthesized, characterized by 1H and 13C NMR and FTIR spectroscopy and tested for bioactivity as potential insulin-mimetic agents. All dioxovanadium(v) complexes exhibited essentially no in vitro insulin-mimetic activity, but the VO2L2 complex developed activity in the presence of ascorbic acid, similar to that of vanadyl sulfate. The molecular structure of the novel complex VO2L1 has been solved by X-ray diffraction methods. It crystallizes in the tetragonal space group P4 2/n with a = 12.7674(7), c = 11.5308(5) A, and Z = 8. The vanadium atom is in a distorted square-pyramidal coordination, with L 1 acting as a tridentate ligand through its azomethyne nitrogen atom, carbonyl oxygen atom and deprotonated phenol oxygen atom. The coordination sphere is completed by two oxo ligands at cis positions. Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, Germany, 2004.

Spectroscopic studies, structural characterization and electrochemical studies of two cobalt (III) complexes with tridentate hydrazone Schiff base ligands: Evaluation of antibacterial activities, DNA-binding, BSA interaction and molecular docking

Fekri, Roghayeh,Salehi, Mehdi,Asadi, Asadollah,Kubicki, Maciej

, (2018)

Co(III) complexes of tridentate Schiff base ligands derived from N-(2-hydroxybenzylideneamino)benzamide (H2L1) and 2-(2-hydroxybenzylidene)hydrazine-1-carboxamide (H2L2) were synthesized and characterized using

Spin-crossover behavior of neutral iron(iii) complexes with salicylaldehyde thio-, seleno- and semicarbazone ligands: Experiment and theoretical analysis

Spitsyna, Nataliya G.,Blagov, Maxim A.,Lazarenko, Vladimir A.,Zorina, Leokadiya V.,Vasiliev, Alexander N.,Krapivin, Vladimir B.,Svetogorov, Roman D.,Maximova, Olga V.,Simonov, Sergey V.,Yagubskii, Eduard B.

, p. 9328 - 9336 (2019)

The iron(iii) complex [Fe(Hsemsal)(semsal)]·3H2O (1) (H2semsal-salicylaldehyde semicarbazone) has been synthesized and characterized by powder and single crystal X-ray diffraction, and magnetic susceptibility measurements. Crystal st

Synthesis, characterization, molecular structure and supramolecular architectures of some copper(II) complexes derived from salicylaldehyde semicarbazone

Salem, Nahed M.H.,Rashad, Amal R.,El Sayed, Laila,Foro, Sabine,Haase, Wolfgang,Iskander, Magdi F.

, p. 231 - 242 (2015)

A series of new copper(II) complexes, [Cu(HSalsc)Cl]·1/2H2O (1), [{Cu(HSalsc)}2(NO3)2][{Cu(HSalsc)}2(NO3)·H2O]NO3 (2), [{Cu(Salsc)}2]H2O (3), [Cu

Salicylaldehyde Semicarbazone-Acetic Acid Hydrogen-Bonded Complex

Abboud, Khalil A.,Summers, Stephen P.,Palenik, Gus J.

, p. 1707 - 1709 (1995)

The crystals of C8H9N3O2*C2H4O2 consist of a one-to-one ratio of salicylaldehyde semicarbazone and acetic acid.Each molecule of salicylaldehyde semicarbazone is joined to an acetic acid molecule by a double hydrogen bond.This arrangement is very similar t

Structure and spectral properties of dinuclear zinc complex containing semicarbazonate ligands

Jing-Lin, Wang,Jiao, Feng,Mei-Ping, Xu,Bin-Sheng, Yang

, p. 1245 - 1249 (2011)

The dinuclear Zn2+ complex [Zn(HSSC)OAc]2·2DMF (H2SSC = salicylaldehyde semicarbazone; HOAc = acetic acid; DMF = N,N-dimethylfomamide) was prepared and structurally characterized by single crystal X-ray. The basic structural unit of the complex is a dinuclear complex [Zn(HSSC)OAc]2 in which the semicarbazone ligand adopts the phenol-imine form. The deprotonated phenol group forms a one-atom bridge between the two zinc centers, and both of the zinc centers are five-coordinated. The local coordination environment of Zn2+ can be approximately considered as square pyramidal. UV spectral studies show that the H 2SSC provides strong binding of Zn2+ in a 1:1 ratio in solution. The conditional binding constant of the complex is lg KZn-L = 12.89 ± 0.76 in 0.05 M Tris-HCl buffer at pH 7.4. The H2SSC exhibits an enhanced fluorescence effect by the addition of Zn2+, and affords an excellent selectivity for Zn2+ under physiological conditions.

Exploring Oxidovanadium(IV) Complexes as YopH Inhibitors: Mechanism of Action and Modeling Studies

Martins, Priscila G. A,Mori, Mattia,Chiaradia-Delatorre, Louise D,Menegatti, Angela C. O,Mascarello, Alessandra,Botta, Bruno,Benítez, Julio,Gambino, Dinorah,Terenzi, Hernán

, p. 1035 - 1040 (2015)

YopH tyrosine phosphatase, a virulence factor produced by pathogenic species of Yersinia, is an attractive drug target. In this work, three oxidovanadium(IV) complexes were assayed against recombinant YopH and showed strong inhibition of the enzyme in the

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 3030-97-5